Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Charlotte Pawlyn(Royal Marsden NHS Foundation Trust), Faith E. Davies(Institute of Cancer Research)
Blood Cancer Journal
March 31, 2017
Cited by 105


Related Papers